| Prevalence and prognosis of COPD in critically ill patients between 1998 and 2008 GC Funk, P Bauer, OC Burghuber, A Fazekas, S Hartl, H Hochrieser, ... European Respiratory Journal 41 (4), 792-799, 2013 | 97 | 2013 |
| Evaluation of 36 formulas for calculating plasma osmolality AS Fazekas, GC Funk, DS Klobassa, H Rüther, I Ziegler, R Zander, ... Intensive care medicine 39, 302-308, 2013 | 94 | 2013 |
| Comparison of RECIST, iRECIST, and PERCIST for the evaluation of response to PD-1/PD-L1 blockade therapy in patients with non–small cell lung cancer L Beer, M Hochmair, AR Haug, B Schwabel, D Kifjak, W Wadsak, ... Clinical nuclear medicine 44 (7), 535-543, 2019 | 62 | 2019 |
| Carboxyhemoglobin levels in medical intensive care patients: a retrospective, observational study AS Fazekas, M Wewalka, C Zauner, GC Funk Critical Care 16, 1-8, 2012 | 37 | 2012 |
| Long-term outcomes after acute hypercapnic COPD exacerbation: First-ever episode of non-invasive ventilation AS Fazekas, M Aboulghaith, RC Kriz, M Urban, MK Breyer, ... Wiener klinische Wochenschrift 130, 561-568, 2018 | 25 | 2018 |
| Rising serum sodium levels are associated with a concurrent development of metabolic alkalosis in critically ill patients G Lindner, C Schwarz, H Grüssing, N Kneidinger, A Fazekas, GC Funk Intensive care medicine 39, 399-405, 2013 | 24 | 2013 |
| Effects of salinomycin and niclosamide on small cell lung cancer and small cell lung cancer circulating tumor cell lines M Hochmair, B Rath, L Klameth, E Ulsperger, C Weinlinger, A Fazekas, ... Investigational new drugs 38, 946-955, 2020 | 19 | 2020 |
| Treatment of ALK-rearranged non-small-cell lung cancer with brigatinib as second or later lines: real-world observations from a single institution M Hochmair, C Weinlinger, S Schwab, J Naber, U Setinek, D Krenbek, ... Anti-Cancer Drugs 30 (7), 740-744, 2019 | 9 | 2019 |
| Rapid Clinical and Radiologic Responses With Larotrectinib Treatment in a Patient With TRK-Fusion–Positive Metastatic Lung Cancer MJ Hochmair, U Setinek, D Krenbek, A Fazekas, O Illini, C Weinlinger, ... Clinical Lung Cancer 21 (2), e49-e53, 2020 | 5 | 2020 |
| O1. EGFR, EML4-ALK and ROS 1 testing in Austrian patients with NSCLC: a multicentre study MJ Hochmair, S Holzer, U Setinek, A Mohn-Staudne, K Kirchbacher, ... Translational Lung Cancer Research 3 (5), 2014 | 2 | 2014 |
| P2. 13-03 Real-Life Experience with Brigatinib in Pretreated EML4-ALK Translocated NSCLC Patients M Hochmair, J Naber, S Schwab, U Setinek, D Krenbek, M Holzer, ... Journal of Thoracic Oncology 13 (10), S799, 2018 | 1 | 2018 |
| Metabolic tumor volume and sites of organ involvement predict outcome in NSCLC immune-checkpoint inhibitor therapy D Kifjak, M Hochmair, D Sobotka, AR Haug, R Ambros, F Prayer, ... European Journal of Radiology 170, 111198, 2024 | | 2024 |
| Real-Life Experience and Clinical Characterization in Patients with ALK Positive NSCLC: A Multicentre Study of the Austrian Lung Cancer Group MJ Hochmair, S Holzer, A Mohn-Staudner, K Kirchbacher, U Setinek, ... JOURNAL OF THORACIC ONCOLOGY 10 (9), S649-S650, 2015 | | 2015 |
| Jahrestagung 2015 der Österreichischen Gesellschaft für Pneumologie PDDB Lamprecht, R Mikes, MRDK Aigner, W Auer, J Bolitschek, P Errhalt, ... Wien Klin Wochenschr 127, 803-839, 2015 | | 2015 |
| Jahrestagung 2014 der Österreichischen Gesellschaft für Pneumologie PDDB Lamprecht, R Mikes, MDK Aigner, J Bolitschek, A Fazekas, H Flick, ... Wien Klin Wochenschr 126, 669-690, 2014 | | 2014 |
| Therapy of a Pleural Tumor with Cortisone T Efstathiades, A Fazekas, MJ Hochmair, M Vesely, MK Breyer, C Pirker, ... WIENER KLINISCHE WOCHENSCHRIFT 125 (19-20), 644-644, 2013 | | 2013 |
| Prevalence and prognosis of critically ill patients with COPD between 1998 and 2008 GC Funk, P Bauer, OC Burghuber, A Fazekas, S Hartl, B Metnitz, ... European Respiratory Journal 38 (Suppl 55), 2011 | | 2011 |
| Prevalence and prognosis COPD in critically ill patients-a prospective cohort study between 1998 and 2008 GC Funk, P Bauer, OC Burghuber, A Fazekas, S Hartl, B Metnitz, ... WIENER KLINISCHE WOCHENSCHRIFT 123 (17-18), A17-A18, 2011 | | 2011 |
